IS ASIA READY FOR BIOSIMILARS? A REVIEW OF THE REGULATORY LANDSCAPE FOR BIOSIMILARS?

被引：0
|
作者：
Duttagupta, S. [1 ]
Park, S. [1 ]
Akandwanaho, D. [1 ]
Jeong, J. J. [1 ]
Feldman, H. [1 ]
机构：
[1] CBPartners, New York, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.430
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP97
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [1] Biosimilars: A Regulatory Review
    Pia Furlani
    Drug information journal : DIJ / Drug Information Association, 2008, 42 : 477 - 485
  • [2] Biosimilars: A regulatory review
    Furlani, Pia
    DRUG INFORMATION JOURNAL, 2008, 42 (05): : 477 - 485
  • [3] Current Market and Regulatory Landscape of Biosimilars
    Bhatt, Valkal
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (21): : S451 - S456
  • [4] Biosimilars: Rationale and current regulatory landscape
    Olech, Ewa
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (05) : S1 - S10
  • [5] Biosimilars: A Critical Review of Development, Regulatory Landscape, and Clinical Implications
    Monga, Ankit
    Gagan, Pragya
    Jamwal, Pragya
    Sharma, Sumit
    Kaur, Amanpreet
    AAPS PHARMSCITECH, 2025, 26 (01):
  • [6] Regulatory considerations in biosimilars: Asia pacific regions
    Rathore, Anurag S.
    Bhargava, Ankita
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2021, 51 (01): : 1 - 8
  • [7] REGULATORY, PRICING AND REIMBURSEMENT LANDSCAPE OF BIOSIMILARS IN AUSTRALIA
    Patel, P.
    Tripathi, S.
    Chauhan, E.
    Jain, A.
    VALUE IN HEALTH, 2017, 20 (05) : A44 - A44
  • [8] Biosimilars are coming: ready or not
    Zalcberg, John
    INTERNAL MEDICINE JOURNAL, 2018, 48 (09) : 1027 - 1034
  • [9] Update on Biosimilars in Asia
    Wen-Chan Tsai
    Current Rheumatology Reports, 2017, 19
  • [10] Update on Biosimilars in Asia
    Tsai, Wen-Chan
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (08)
12345